Evidence map›Paper›PMID 20164255›Full record

ArticleClinical and vaccine immunology : CVI2010

Immunological fingerprinting method for differentiation of serum samples in research-oriented biobanks.

Katy Beaumont, Fotini Betsou

Abstract readEvaluation Study
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Katy BeaumontBiobanque de Picardie, Centre Hospitalier Universitaire d'Amiens, av. René Laënnec, 80480 Salouel, France.
Fotini Betsou

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An immunoenzymatic serum fingerprinting method was developed to establish a serum sample fingerprint based on IgG titers obtained with three different antigens. Three widely expressed antigens were selected for their capacity to induce long-lasting humoral immune responses. This fingerprinting method may be used to differentiate between two serum samples and to determine whether they come from the same primary blood specimen. The method showed a specificity of 99.5%. This method is suitable as a quality control method for biobanked serum samples.

Indexed as

Biological Specimen BanksAdolescentAdultAntibodies, BacterialAntibodies, ViralBacterial Outer Membrane ProteinsBordetella pertussisChlamydophila pneumoniaeEpstein-Barr Virus Nuclear AntigensFemaleHerpesvirus 4, HumanHumansImmunoglobulin GMiddle AgedPertussis ToxinSensitivity and SpecificityAntibodies, BacterialAntibodies, ViralBacterial Outer Membrane ProteinsEBV-encoded nuclear antigen 1Epstein-Barr Virus Nuclear AntigensImmunoglobulin GOmp2 protein, bacteriaPertussis Toxin

Identifiers

PMID20164255
PMCPMC2863373

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.